---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-050646"
form_type: "8-K"
ticker: "INBS"
cik: "0001725430"
company_name: "INTELLIGENT BIO SOLUTIONS INC."
filed_at: "2024-12-18T23:59:59+00:00"
generated_at: "2026-05-29T02:02:24.016716+00:00"
event_type: "regulatory"
sentiment: "positive"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# INBS files 510(k) with FDA for fingerprint sweat drug test; 94.1% accuracy, 2025 US launch target

## Summary
- 510(k) submission for Intelligent Fingerprinting Drug Screening System; method comparison study showed 94.1% accuracy.
- PK study demonstrated fingerprint sweat drug detection closely aligned to blood at 95% confidence level.
- System provides non-invasive results within 10 minutes; already adopted in international markets.
- US market entry planned for 2025; targets safety-critical industries (construction, mining, transportation).
- Potential applications in law enforcement, drug rehabilitation, and forensic sectors for diverse revenue streams.

## SEC filing metadata
- accession: 0001493152-24-050646
- form_type: 8-K
- ticker: INBS
- cik: 0001725430
- company_name: INTELLIGENT BIO SOLUTIONS INC.
- filed_at: 2024-12-18T23:59:59+00:00
- event_type: regulatory
- sentiment: positive
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1725430/000149315224050646/0001493152-24-050646-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1725430/000149315224050646/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-050646
- JSON: https://secwatch.observer/filing/0001493152-24-050646.json
- Plain text: https://secwatch.observer/filing/0001493152-24-050646.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.